Why reproducibility remains a challenge in preclinical research

Improving reproducibility requires more than stronger statistics alone. Across the research community, scientists are adopting new approaches to increase transparency, standardization, and rigor at every stage of the experimental workflow. Read this article to explore emerging strategies for strengthening reproducibility and building more robust preclinical studies. https://www.drugdiscoverynews.com/why-reproducibility-remains-a-challenge-in-preclinical-research-17198?utm_campaign=DDN%20Lead%20Generation&utm_medium=email&_hsenc=p2ANqtz-9SqHrV_7KQATNvLY977Pj57WOQGa71BxP4K1ICIj-HzN5Oc6GJ5egjQe9NsWqD67p_xHh_goN_nn0cH1rxU3PtIwHdjw&_hsmi=435425482&utm_content=435425482&utm_source=hs_email